AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

ELI LILLY & Co Director's Dealing 2023

Jul 7, 2023

29745_dirs_2023-07-07_efd796eb-c886-4ca0-8273-dbc00b7337e9.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Sigilon Therapeutics, Inc. (SGTX)
CIK: 0001821323
Period of Report: 2023-06-28

Reporting Person: ELI LILLY & Co (10% Owner)
Reporting Person: Shenandoah Acquisition Corp (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	211110	Direct